Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors

Clinical trial NCT00025675 · COMPLETED

Trial details

NCT number: NCT00025675
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors

Start date: 2001-10-09
Primary completion: 2006-07-05
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.